Target intelligence / Profile preview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 28 (MTND1P28)

Target
MTND1P28
Molecular classification
Other (Pseudogene)
01

Overview

MT-ND1 pseudogene 28 (MTND1P28) is a nuclear pseudogene with sequence similarity to the mitochondrial gene MT-ND1, which encodes a core subunit of Complex I of the mitochondrial electron transport chain. Unlike the authentic MT-ND1 gene, which is essential for mitochondrial energy production and is implicated in disorders such as Leber hereditary optic neuropathy and MELAS, MTND1P28 does not produce a functional protein and is not known to have an established biological function or direct disease relevance. Current literature and gene databases do not associate it with any therapeutic targeting, biological pathways, or clinical interventions.\n\nKey notes:\n- MTND1P28 is not a therapeutic target, receptor, enzyme, transporter, or functional gene, but is a nuclear pseudogene.\n- There is no evidence of molecular function, associated diseases, or drug interactions.\n- Several similarly named pseudogenes exist (e.g., MTND1P20, MTND1P21, MTND1P23), but they also lack known biological function or clinical utility.\n- The correct therapeutic or biological target is MT-ND1, not MTND1P28.\n\nIf you are seeking a therapeutically relevant target, refer to MT-ND1 (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1), not its pseudogenes.

Other names
MT-ND1 pseudogene 28MTND1P28mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 28

Beyond the preview

Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 28 (MTND1P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 28 (MTND1P28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call